PATH | VRL
Menu

Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants

This study, published in the New England Journal of Medicine, assessed the feasibility of integrating the RTS,S/AS02D malaria vaccine into a standard expanded program on immunization (EPI) schedule for infants. The study, conducted in Tanzania, showed that the use of the RTS,S/AS02D vaccine in infants had a promising safety profile, did not interfere with the immunologic responses to coadministered EPI antigens, and reduced the incidence of malaria infection.

Author: Abdulla S, Oberholzer R, Juma O, et al.

Published: 2008

» Visit web page (English)

(Located at content.nejm.org)

Citation: Abdulla S, Oberholzer R, Juma O, et al. Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants. New England Journal of Medicine. 2008;359(24):2533-2544.

Resource types: Peer-reviewed journal

Diseases/vaccines: Malaria

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: Africa